BSE filing, NSE: SMT. Summary written from the filing by ALFA Finder's alert engine.
Sahajanand Medical Technologies Ltd: key numbers
- Share price
- ₹471.05
- Market cap
- ₹4,788 Cr
- Revenue (annual)
- ₹1,210 Cr
- Net profit (annual)
- ₹65.28 Cr
- Promoter holding
- 36.20%
- FII holding
- 35.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sahajanand Medical Technologies Ltd
All →Sahajanand Medical Technologies Capital Structure Change
Invesco Mutual Fund schemes bought 44,20,453 Sahajanand Medical Technologies shares in the open market. Their stake rose to 5.0549%, with no transaction price disclosed.
Sahajanand Medical Technologies Board Meeting Date
Sahajanand Medical Technologies scheduled a board meeting for 5 November 2026 to consider Q2 and half-year financial results. No financial figures are disclosed yet.
Sahajanand Medical Technologies Legal & Regulatory
Sahajanand Medical Technologies received a DGGI summons under GST Act Section 70 for books verification. The company says there is no material financial impact at this stage.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.